ESCRS 2023

Join a panel of canaloplasty surgeons at Exhibit #114 (Hall C) to learn about the utility of iTrack Advance.

Make sure to stop by Exhibit #114 (Hall C) on Saturday and Sunday to take part in the iTrack Advance Speaker Forum and learn about the utility of canaloplasty in the glaucoma treatment paradigm. A stent-free, tissue-sparing MIGS procedure, canaloplasty treats all points of outflow resistance in the conventional outflow pathway to effectively reduce IOP and medication burden. 

Saturday, September 9

Speaker Forum

10:0011:00am
Nova Eye Exhibit

Faculty:

Karl Mercieca, MD (Germany)
Ike Ahmed, MD (Canada)

Sunday, Sep 10

Speaker Forum (topic TBC)

12:001:00pm
Nova Eye Exhibit

Faculty:
Karsten Klabe, MD (Germany)
I. Paul Singh, MD (USA)

Note: These sessions are not affiliated with the official program of the ESCRS 2023

Meet the Experts at Exhibit #114 to discuss surgical pearls and treatment tips for the iTrack™ Advance.

Make sure to stop by the Nova Eye Exhibit #114 (Hall C) on Saturday and Sunday to spend some time with a canaloplasty expert and discuss their surgical pearls and treatment tips for the new iTrack™ Advance. Refreshments available. 

Saturday, September 9

Meet the Expert

3:304:30pm
Nova Eye Exhibit #114 (Hall C)

Faculty:
Ike Ahmed, MD (Canada)
James Murphy, MD (USA)
Robert Noecker, MD (USA)
I. Paul Singh, MD (USA)

Sunday, September 10

Meet the Expert

4:005:00pm
Nova Eye Exhibit #114 (Hall C)

Faculty:
I. Paul Singh, MD (USA)
Karl Mercieca, MD (Germany)
James Murphy, MD (USA)
Ticiana de Francesco (Brazil)

Note: These sessions are not affiliated with the official program of the ESCRS 2023.

Visit us at Exhibit #114 to learn about the new iTrack™ Advance for canaloplasty – and take part in a hands-on demo.

The iTrack™ Advance is arguably the world’s most advanced canaloplasty device. Built on the tried and tested iTrack™ platform, which has been used in more than 120,000 canaloplasty procedures globally, the new iTrack™ Advance combines the world’s only illuminated canaloplasty microcatheter with an easy-to-use handheld injector and custom cannula. But don’t just take our word for it. Visit us Exhibit #114 to take part in a hands-on demo. 

Canaloplasty on the podium at the ESCRS 2023

Canaloplasty will feature in a number of papers and posters at the ESCRS 2023. Please see the summary below and review the official ESCRS program for more details.

Multicenter Ab-Interno Canaloplasty Glaucoma Data Registry – Outcomes Across Glaucoma Type And Severity
Free paper podium presentation

Keith Barton

Efficacy of Ab-Interno Canaloplasty with the iTrack Performed With And Without GATT following Previous Glaucoma Laser Treatment
Presented poster: PP23.12

James Murphy, MD (USA)

Efficacy and Safety Profile of Ab-Interno Canaloplasty Performed With And Without GATT – 12-Month Outcomes
E-poster: PO0851

James Murphy, MD (USA)

iTrack Global Data Registry to Support the Role of Canaloplasty for Treatment of Glaucoma
E-poster: PO0845

David Lubeck, MD (USA)

Endothelial Cell Density and Loss Following Ab-Interno Canaloplasty in Patients with Mild-Moderate Glaucoma as Compared to Severe Glaucoma
E-poster: PO0844

David Lubeck, MD (USA)

6-Year Clinical Effectiveness of Ab-Interno Canaloplasty in Reducing the Medication Burden In Glaucoma Patients
E-poster: PO0881

Norbert Koerber, PhD, MD (Germany)

Contact Us

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More